Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 5:31 pm Purchase |
2024-12-31 | 13G | Silexion Therapeutics LTD SLXN |
GOLDMAN SACHS GROUP INC GS |
112,242 6.600% |
112,242 (New Position) |
Filing History |
| 2025-01-23 12:19 pm Purchase |
2025-01-15 | 13G | Silexion Therapeutics LTD SLXN |
CVI Investments, Inc. | 339,000 8.500% |
339,000 (New Position) |
Filing History |
| 2025-01-21 5:49 pm Purchase |
2025-01-15 | 13G | Silexion Therapeutics LTD SLXN |
Mitchell P. Kopin | 209,827 4.990% |
209,827 (New Position) |
Filing History |
| 2024-11-20 06:15 am Purchase |
2024-08-15 | 13D | Silexion Therapeutics LTD SLXN |
Guangzhou Sino-Israel Bio-Industry Investment Fund LLP | 220,787 13.800% |
220,787 (New Position) |
Filing History |
| 2024-08-22 6:44 pm Purchase |
2024-08-15 | 13D | Silexion Therapeutics LTD SLXN |
Wildcat Capital Management, LLC | 113,428 10.500% |
113,428 (New Position) |
Filing History |
| 2024-08-22 5:23 pm Purchase |
2024-08-15 | 13D | Silexion Therapeutics LTD SLXN |
Moringa Sponsor LP | 229,623 20.800% |
229,623 (New Position) |
Filing History |